Cephalexin 50 mg/kg/day divided three times daily is appropriate for this child with uncomplicated non-purulent cellulitis
For a 6-year-old child (~20 kg) with uncomplicated non-purulent cellulitis and no β-lactam allergy, cephalexin 50 mg/kg/day divided into three doses is an acceptable and effective regimen.
Dosing Rationale
The FDA-approved dosing for cephalexin in pediatric patients is 25-50 mg/kg/day in divided doses 1. For skin and soft tissue infections specifically, the IDSA guidelines recommend 25-50 mg/kg/day in 3-4 divided doses 2. Your proposed regimen of 50 mg/kg/day divided three times daily falls within both the FDA label and guideline recommendations.
Practical Calculation for This Patient
- Total daily dose: 20 kg × 50 mg/kg = 1000 mg/day
- Per-dose amount: ~333 mg three times daily
- Using 250 mg/5 mL suspension: approximately 1.5 teaspoons (7.5 mL) three times daily
Evidence Supporting Three Times Daily Dosing
Recent high-quality pediatric data strongly supports this approach:
- A 2022 retrospective study of 117 children with moderate cellulitis treated with high-dose oral cephalexin showed an 89.7% success rate with excellent safety profile 3
- A 2025 study specifically validated 45 mg/kg/dose (maximum 1.5 g) three times daily in children with bone and joint infections, achieving 99% cure rates with good tolerability 4
- Pharmacokinetic modeling confirms that three times daily dosing at this dose achieves appropriate pharmacodynamic targets 4
Key Advantages of This Regimen
Improved adherence: Three times daily dosing is significantly more practical than the traditional four times daily regimen, which improves real-world compliance without sacrificing efficacy 4.
Appropriate for non-purulent cellulitis: For uncomplicated non-purulent cellulitis, β-hemolytic streptococci and methicillin-sensitive Staphylococcus aureus are the presumed pathogens 2, 5. Cephalexin provides excellent coverage for these organisms, and MRSA coverage is not recommended for non-purulent cellulitis 2, 5.
Treatment Duration and Monitoring
- Duration: 7-10 days is standard for uncomplicated cellulitis
- Follow-up: Reassess at 48-72 hours to ensure clinical improvement (decreased erythema, swelling, warmth, and tenderness)
- Treatment failure indicators: Fever, increase in erythema >25%, or no improvement by day 3-4 6
Important Caveats
Avoid concurrent acid suppression: One older study suggested potential decreased efficacy when cephalexin is given with acid-suppressive therapy, though this was not statistically significant 7. If the child is on proton pump inhibitors or H2 blockers, consider this interaction.
Monitor for adverse effects: While generally well-tolerated, watch for:
- Gastrointestinal symptoms (most common) 4
- Mild neutropenia (uncommon, typically self-limited) 4
- Diarrhea (occurs in ~4% of patients) 3
When to escalate: If the child develops systemic signs (fever, tachycardia, hypotension) or fails to improve within 48-72 hours, consider IV antibiotics or MRSA coverage 2.
Alternative Consideration
If adherence remains a concern even with three times daily dosing, cefadroxil 40 mg/kg/dose twice daily (maximum 1500 mg/dose) is an evidence-based alternative with similar efficacy and a longer half-life 8.